ACTIVE

Immobilière Général Léman

Financial year 2025 · Closed on 31/12/2025

Net result34,9 k €+30,8 %over 1 year
Gross margin92 k €+12,9 %over 1 year
Equity451,5 k €+8,4 %over 1 year

Identity

Source · BCE/KBO

Immobilière Général Léman is a Public limited company incorporated in 1968. Its registered office is in Frameries.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0403.358.761
Incorporation
01/01/1968
Legal form
Public limited company
Registered office
Rue Montavaux 155
7080 Frameries · WallonieSee on map
Contributed capital
61 973,00 €
Latest accounts
31/12/2025
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 20 filings

Trend over 20 financial years

20252024202320222021
Income statement
Gross margin92 k €81,5 k €84,2 k €88,1 k €105,2 k €
EBITDA81,9 k €71,7 k €74,8 k €79,5 k €96,8 k €
Operating result44,7 k €35,2 k €39,4 k €44 k €61,5 k €
Net result34,9 k €26,7 k €29,5 k €31,7 k €45 k €
Balance sheet
Equity451,5 k €416,5 k €439,8 k €510,4 k €478,7 k €
Total assets454,4 k €467,2 k €540,7 k €513,7 k €505,8 k €
Cash236 k €220,1 k €251 k €205,8 k €165,8 k €
Debts2,9 k €50,7 k €100 k €3,3 k €27,1 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 22 ended

Active mandates

GESTIPHARMA

Managing director · since 25 novembre 2022 · until 24 novembre 2028 · 0425.530.684

Represented by PIERRE-PASCAL HECQ

Active
WINGS FARMA

Director · since 25 novembre 2022 · until 24 novembre 2028 · 0550.851.716

Represented by PIERRE-PHILIPPE HECQ

Active

Ended mandates

GESTIPHARMA

Managing director · since 28 mai 2022 · until 27 mai 2028 · 0425.530.684

Represented by PIERRE-PASCAL HECQ

Ended
WINGS FARMA

Director · since 28 mai 2022 · until 27 mai 2028 · 0550.851.716

Represented by PIERRE-PHILIPPE HECQ

Ended
GESTIPHARMA

Managing director · since 27 mai 2017 · until 28 mai 2022 · 0425.530.684

Represented by PIERRE-PASCAL HECQ

Ended
FINPHARMA

Director · since 28 mai 2016 · until 28 mai 2022

Represented by ALPHONSE MANGEN

Ended

Other companies at this address

Rue Montavaux 155 7080 Frameries
CompanyCBE no.
ASSCOT● Active
0447.778.625
0478.169.913
BEPHAR● Active
0450.260.538
EVRAS● Active
0417.723.174
FARMIMMO● Active
0429.198.175
FELIX PHARMA● Active
0477.939.091
0443.155.782
0466.956.812
0435.700.442
0403.082.213
OBIPHAR● Active
0878.100.418
0882.318.631
0423.162.203
0867.368.654
0842.900.009
0479.179.208
0419.745.130
0447.088.737
0439.400.397
PHARMANET● Active
0426.485.640

Full financial information

Source · NBB
202520242023202220212020
Type of accountMicro modelMicro modelMicro modelMicro modelMicro modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date30/06/202614/07/202506/08/202423/08/202318/08/202209/08/2021
General meeting30/05/202631/05/202525/05/202427/05/202328/05/202229/05/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202530/05/202630/06/2026FrenchPDF
Micro model31/12/202431/05/202514/07/2025FrenchPDF
Micro model31/12/202325/05/202406/08/2024FrenchPDF
Micro model31/12/202227/05/202323/08/2023FrenchPDF
Micro model31/12/202128/05/202218/08/2022FrenchPDF
Abridged model31/12/202029/05/202109/08/2021FrenchPDF
Abridged model31/12/201930/05/202025/08/2020FrenchPDF
Abridged model31/12/201825/05/201907/08/2019FrenchPDF
Abridged model31/12/201726/05/201820/07/2018FrenchPDF
Abridged model31/12/201627/05/201704/07/2017FrenchPDF
Abridged model31/12/201528/05/201603/08/2016FrenchPDF
Abridged model31/12/201430/05/201512/08/2015FrenchPDF
Abridged model31/12/201331/05/201423/07/2014FrenchPDF
Abridged model31/12/201225/05/201325/06/2013FrenchPDF
Abridged model31/12/201126/05/201209/07/2012FrenchPDF
Abridged model31/12/201028/05/201108/07/2011FrenchPDF
Abridged model31/12/200929/05/201004/06/2010FrenchPDF
Abridged model31/12/200806/06/200926/06/2009FrenchPDF
Abridged model31/12/200717/05/200819/05/2008FrenchPDF
Abridged model31/12/200605/05/200707/05/2007FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 22 ended

Active mandates

GESTIPHARMA

Managing director · since 25 novembre 2022 · until 24 novembre 2028 · 0425.530.684

Represented by PIERRE-PASCAL HECQ

Active
WINGS FARMA

Director · since 25 novembre 2022 · until 24 novembre 2028 · 0550.851.716

Represented by PIERRE-PHILIPPE HECQ

Active

Ended mandates

GESTIPHARMA

Managing director · since 28 mai 2022 · until 27 mai 2028 · 0425.530.684

Represented by PIERRE-PASCAL HECQ

Ended
WINGS FARMA

Director · since 28 mai 2022 · until 27 mai 2028 · 0550.851.716

Represented by PIERRE-PHILIPPE HECQ

Ended
GESTIPHARMA

Managing director · since 27 mai 2017 · until 28 mai 2022 · 0425.530.684

Represented by PIERRE-PASCAL HECQ

Ended
FINPHARMA

Director · since 28 mai 2016 · until 28 mai 2022

Represented by ALPHONSE MANGEN

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates28/11/2024
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates11/01/2023
    OBJET - DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Mandates09/09/2022
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates18/11/2019
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates09/10/2017
    DEMISSIONS, NOMINATIONS
    PDF
  • Other29/10/2013
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Capital / shares14/02/2012
    CAPITAL, ACTIONS
    PDF
  • Registered office27/05/2011
    SIEGE SOCIAL
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202534,9 k €↑
  2. 2024
    Annual accounts 202426,7 k €↓
  3. 2023
    Annual accounts 202329,5 k €↓
  4. 2022
    Annual accounts 202231,7 k €↓
  5. 2021
    Annual accounts 202145 k €↓
  6. 2020
    Annual accounts 202046,4 k €↑
  7. 2019
    Annual accounts 201940,1 k €↑
  8. 2018
    Annual accounts 201837,6 k €↑
  9. 2017
    Annual accounts 201732,6 k €↓
  10. 2016
    Annual accounts 201634,1 k €↑
  11. 2015
    Annual accounts 201530,5 k €↑
  12. 2014
    Annual accounts 201418,6 k €↓
  13. 2013
    Annual accounts 201334,9 k €↑
  14. 2012
    Annual accounts 2012-10,1 k €↑
  15. 2011
    Annual accounts 2011-11,8 k €↓
  16. 2010
    Annual accounts 201029,4 k €↑
  17. 2009
    Annual accounts 200928,6 k €↑
  18. 2008
    Annual accounts 200826,5 k €↑
  19. 2007
    Annual accounts 200726,4 k €↑
  20. 2006
    Annual accounts 200622,4 k €
  21. 01/01/1968
    IncorporationPublic limited company